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Family and twin studies have identified endophenotypes that
capture familial and genetic risk in attention-deficit/hyperactivity
disorder (ADHD), but it remains unclear if they lie on the causal
pathway. Here, we illustrate a stepwise approach to identifying
intermediate phenotypes. First, we use previous quantitative gen-
etic findings to delineate the expected pattern of genetically corre-
lated phenotypes. Second, we identify overlapping genetic
associations with ADHD-related quantitative traits. Finally, we
test for the mediating role of associated endophenotypes. We
applied this approach to a sample of 1,312 twins aged 7–10. Based
onprevious twinmodel-fitting analyses,we selectedhyperactivity–
impulsivity, inattention, reading difficulties (RD), reaction time
variability (RTV) and commission errors (CE), and tested for
associationwith selected ADHD risk alleles. For nominally signifi-
cant associations with both a symptom and a cognitive variable,
matching the expected pattern based on previous genetic correla-
tions, we performed mediation analysis to distinguish pleiotropic
frommediating effects. The strongest associationwas observed for
the rs7984966 SNP in the serotonin receptor gene (HTR2A), and
RTV (P¼ 0.007; unadjusted for multiple testing). Mediation anal-
ysis suggested that CE (38%) and RTV (44%) substantially medi-
ated the association between inattention and the T-allele of SNP
rs3785157 in the norepinephrine transporter gene (SLC6A2) and
theT-alleleofSNPrs7984966 inHTR2A, respectively.TheSNPs tag
risk-haplotypes but are not thought to be functionally significant.
While these exploratory findings are preliminary, requiring repli-
cation, this study demonstrates the value of this approach that can
be adapted to the investigation of multiple genetic markers and
polygenic risk scores.  2016 The Authors. American Journal of Medical
Genetics Part B: Neuropsychiatric Genetics Published by Wiley Periodicals, Inc.
Key words: endophenotype; RTV; inhibition; inattention;
hyperactivity–impulsivity; reading difficulties
INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is character-
ized by developmentally inappropriate levels of inattention
and hyperactivity–impulsivity. In addition to the core behavioral
symptoms, ADHD is associated with multiple cognitive impair-
ments [Kuntsi et al., 2010; Frazier-Wood et al., 2012]. Family and
twin studies have been largely successful in identifying cognitive
phenotypes that capture the familial-genetic risk in ADHD.
Using a large sample of ADHD and control sibling pairs, we
previously identified the separation of slow and highly variable
reaction times (RTs) (reflecting lapses in attention) from com-
mission and omission errors on a go/no-go task (reflecting
difficulties with response inhibition and failures to respond to
a signal), into two familial factors [Kuntsi et al., 2010]. We also
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showed that the familial influences that ADHD shares with these
cognitive impairment measures are largely separate from those
that ADHD shares with IQ [Wood et al., 2010b]. More recently,
we found that ADHD shares familial risks with reading difficul-
ties (RD), and that this is largely independent of the familial risk
factors shared between ADHD and IQ [Cheung et al., 2012].
Comparable findings were found in separate analyses on a large
Dutch sample of ADHD and control sibling pairs using a
different cognitive test battery. Two familial cognitive imp-
airment factors again emerged, with the first capturing the speed
and variability of responses across several tasks, and the second
capturing aspects of executive functioning, such as working
memory [Frazier-Wood et al., 2012]. Familial influences on
IQ were again largely separate: while the second familial factor
captured 33% of the familial influences on IQ, 67% were not
accounted for by the model [Frazier-Wood et al., 2012].
Using a population-based twin sample, we recently replicated the
etiological separation of reaction time variability (RTV) and com-
mission errors (CE) [Kuntsi et al., 2014] that we had previously
observed in the sample with clinically diagnosed ADHD [Kuntsi
et al., 2010]. Further analyses on the twin sample also replicated the
finding of the genetic overlap between ADHD symptoms and
cognitive impairments (including RD) being largely distinct from
the effectof IQ[Paloyelis et al., 2010;Woodet al., 2010a].Examining
the etiological pathways separately for the two ADHD symptom
dimensions, we found a strong genetic overlap between RTV and
inattention symptoms [Kuntsi et al., 2014]. Although RTV was also
significantly genetically associated with hyperactivity–impulsivity,
the majority (55%) of the genetic covariance between inattention
and RTV occurred independently of the genetic effects underlying
hyperactivity–impulsivity [Kuntsi et al., 2014]. RD also shared a
greater genetic risk with inattention versus hyperactivity–
impulsivity symptoms [Paloyelis et al., 2010].
The comparability of these findings across both diagnostic and
dimensional approaches to the ADHD phenotype is consistent
with evidence from family and twin studies that the clinical
diagnosis of ADHD reflects the extreme and impairing tail end
of one or more continuous dimensions of psychopathology [Levy
et al., 1997; Chen et al., 2008; Larsson et al., 2014]. Moreover, the
findings highlight the importance of both shared and unique
etiological pathways on the two ADHD symptom dimensions of
inattention and hyperactivity–impulsivity [McLoughlin et al.,
2007, 2011; Greven et al., 2011].
The cognitive phenotypes identified in these studies (such as
RTVandCE) are often assumed to be intermediate phenotypes that
lie on the causal pathway from genes to ADHD symptoms, since
they are identified by the same genes that increase risk for ADHD.
However, genetically correlated phenotypes may also reflect plei-
otropy, whereby overlapping sets of genes give rise to multiple
phenotypes that index genetic risk, but do not mediate between
genes and the clinical phenotype [Kendler and Neale, 2010]. This
distinction is important, as intermediate phenotypes, which are
hypothesized to lie on the causal pathway from genes to a clinical
phenotype, are potential targets for treatment and prevention of
ADHD, whereas risk-liability biomarkers reflect correlated phe-
notypes that play no direct causal role in the disorder [Kendler and
Neale, 2010]. The distinction between pleiotropic and mediating
genetic effects is widely assumed, but in the absence of formal
testing it is not possible to distinguish between these effects
[Asherson and Gurling, 2012].
As yet, only a few studies have investigated the mediating role of
phenotypes in pathways from genetic variants to ADHD symp-
toms. One study found the association between the high-activity
catechol-O-methyltransferase gene (COMT) valine/valine geno-
type and antisocial behavior in ADHD was partially mediated by
impaired social cognition, whereas impairments in executive con-
trol represented pleiotropic effects (i.e., genetically correlated but
non-mediating effects) [Langley et al., 2010]. Another study using a
series of regression analyses on 11 different measures of executive
functioning found no evidence that they mediated the association
between three single nucleotide polymorphisms (SNPs) in the
adrenergic receptor a2A gene (ADRA2A) and ADHD affection
status [Waldman et al., 2006]. In a study investigating ADHD
symptoms, low conscientiousness and high neuroticism were
found to partially mediate the association between a genetic
composite (based on the number of risk alleles for DRD4,
DAT1, and ADRA2A) and the inattentive symptoms of ADHD
[Martel et al., 2010].
Overall, our knowledge of the causal links from genetic risk
markers to ADHD remains very limited, in particular for the two
ADHD symptom dimensions of inattention and hyperactivity–
impulsivity considered separately. The aim of this study was,
therefore, to address this gap by using genetic variants reported
to be associated with ADHD in previous studies, to look for
overlapping associations with both ADHD symptoms and cogni-
tive performance. Then in a second step, we explicitly test for the
mediating role of phenotypes in the association with ADHD
genetic risk variants.
The selection of genetic variants for this study was based on
candidate gene association findings with the dopaminergic, nor-
adrenergic and serotoninergic neurotransmitter systems that had
previously been reported to be associated with ADHD. Pharma-
cological, neuroimaging, and animal studies have established a role
of these neurotransmitter systems in ADHD. For example, the
main pharmacological action of stimulant mediation used to treat
ADHD, such as methylphenidate and dexamphetamine, is to
increase synaptic dopamine, generating much interest in genes
involved in dopaminergic pathways. Adrenergic and serotonergic
neurotransmission is also affected by ADHD medications. More-
over, there is evidence for a role of serotoninergic dysfunction in
impulsive behavior in both human and animal studies [Koskinen
et al., 2000a,b; Lesch and Merschdorf, 2000; Walderhaug et al.,
2002]. Thus, converging evidence led to genes involved in the
dopaminergic, noradrenergic and serotonergic systems to rank
among the most frequently investigated in targeted candidate gene
association studies of ADHD.
We selected SNPs and variable number tandem repeat (VNTR)
polymorphisms that had previously provided evidence of associa-
tion with ADHD in two or more studies (see Table I). The genetic
variants were from genes involved in dopaminergic (dopamine
transporter [SLC6A3], dopamine D4 receptor [DRD4], COMT,
monoamine oxidase A [MAOA]), noradrenergic (norepinephrine
transporter [SLC6A2]), and serotoninergic (serotonin 1B receptor
[HTR1B], the serotonin 2A receptor [HTR2A], serotonin trans-
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porter [5-HTT], tryptophan hydroxylase 2 [TPH2]) neurotrans-
mission. We also selected SNPs in the synaptosomal-associated
protein 25 (SNAP-25) gene, as it was one of the strongest
associations that has emerged from meta-analysis of candidate
gene association studies [Gizer et al., 2009]. SNPs were also
included from the Cadherin 13 gene (CDH13), which ranked
among the top hits from genome-wide association studies
(GWAS) [Lasky-Su et al., 2008b; Lesch et al., 2008] and is found
under the significant linkage peak identified in a meta-analysis of
sibling-pair studies [Zhou et al., 2008]. Finally, we tested for SNPs
in the ciliary neurotrophic factor receptor (CNTFR), which had
been reported to be associated in independent samples of children
and adults with ADHD [Ribases et al., 2008]. Further analyses of
SNPs across multiple genes and using polygenic risk scores is
possible using genomewide association data, but at the time of
completing the analyses presented here, further genotyping has not
been completed.
In this study, we illustrate a stepwise approach to identifying
causal pathways from geneticmarkers to ADHD-related ratings, by
testing for associations with ADHD-related quantitative traits and
conducting selected mediation analyses in a general population
twin sample. In the first step, informed by a series of quantitative
geneticmodel-fitting analyses in the same twin sample studying the
etiological relationships across ADHD symptom subscales and
cognitive measures [Paloyelis et al., 2010; Wood et al., 2010a;
Cheung et al., 2014; Kuntsi et al., 2014], we selected ratings of
inattention, hyperactivity–impulsivity, RD, RTV and CE to take
forward to test for association with selected genetic risk variants.
The selected risk variants were all previously reported to be
associated with ADHD in two or more studies (Table I). In the
second step, we conducted mediation analysis where genetic
variants showed nominal overlapping associations with both a
symptom domain and a cognitive variable that matched findings
from the earlier genetic model-fitting studies. The mediation
analysis allows the distinction between a correlated risk-liability
indicator and intermediate phenotypes to be explicitly tested. We
hypothesized that the same pattern of associations with clinical and
cognitive phenotypes should emerge for specific markers, as those
identified from genetic-model fitting. Therefore, this study
presents a proof of principle of the approach to combine quanti-
tative and molecular genetic investigations to delineate causal
pathways underlying ADHD-related symptom ratings.
MATERIALS AND METHODS
Participants
Participants were from the Study of Activity and Impulsivity Levels
in children (SAIL). Sampling methods and data collection proce-
dures are described in detail elsewhere [Kuntsi et al., 2006]. The
parents of all participating children provided informed consent,
with ethical approval obtained from the Research Ethics Commit-
tee of the Institute of Psychiatry, King’s College London, UK. The
present analyses focused on a total of 1,312 children: 513 identical
(monozygotic, MZ) twins (data for 255 complete twin pairs), 374
TABLE I. Genetic Markers Chosen for Genotyping in Population-Based Twin Samplea
Gene Marker Previous association with ADHD Functional Status
CDH13 rs6565113 Association with total symptom count [Lasky-Su et al., 2008b]. Intronic—no known function
CDH13 rs11646411 Associated with adult ADHD [Lesch et al., 2008]. Intronic—no known function
CNTFR rs7036351 Associated with both adult and childhood ADHD [Ribases et al., 2008]. Intronic—no known function
DAT1 Intron 8 VNTR Associated with clinical ADHD in meta-analysis [Gizer et al., 2009]. Altered gene expression
DAT1 30UTR VNTR Associated with clinical ADHD in meta-analyses [Yang et al., 2007;
Gizer et al., 2009].
Altered gene expression
DRD4 Exon 3 VNTR Associated with clinical ADHD in meta-analyses [Li et al., 2006; Gizer
et al., 2009]
Altered receptor response
HTR1B rs6296 Associated with clinical ADHD in meta-analysis [Gizer et al., 2009]. C>G synonymous Val287Val
MAOA rs6323 Gene associated with ADHD [Domschke et al., 2005; Xu et al., 2007]. T-allele associated with low activity MAOA
SLC6A2 rs3785143 Associated with clinical ADHD [Brookes et al., 2006; Kim et al., 2008;
Xu et al., 2008].
Intronic—no known function
SLC6A2 rs3785157 Associated with clinical ADHD [Bobb et al., 2005; Xu et al., 2005], but
with opposing alleles.
Intronic—no known function
SNAP-25 rs1051312 Association found when five independent studies pooled together [Kim
et al., 2007].
30-UTR: Altered gene expression
SNAP-25 rs6077690 Association found when five independent studies pooled together [Kim
et al., 2007].
Promoter region—functional significance
unknown
TPH2 rs1843809 Associated with clinical ADHD [Sheehan et al., 2005; Brookes et al.,
2006], but with opposing allele.
Intronic—no known function
5HT2A rs7322347 Associated with ADHD-C subtype in children (not adults) [Ribases
et al., 2009].
Intronic—no known function
5HT2A rs7984966 Associated with ADHD-C subtype in adults (not children) [Ribases
et al., 2009].
Intronic—no known function
aExcluded markers are not shown.
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same-sex non-identical (dizygotic, DZ) twins (data for 184 com-
plete twin pairs), 427 opposite-sex DZ twins (207 complete twin
pairs) and 22 singletons. Twin zygosity was determined using a
parental-report questionnaire with 95% accuracy, later verified
using DNA [Price et al., 2000]. To check the error rate for twin
zygosity status, we obtained themost recent data available from the
overall TEDS twin dataset. Out of 3,728 twin pairs with genotype
data, three twin pairs were erroneously classified as DZs when
according to genotype data they were MZs, and no twin pairs were
misclassified asMZs, giving an error rate of 0.08%. Themean age of
participating children was 8.83 years (SD¼ 0.67), with a similar
proportion of boys (49.5%) and girls. Children’s IQs ranged from
70 to 158 (mean¼ 109.34, SD¼ 14.72).
Measures
ADHD rating scales. Parents and teachers were asked to
complete the Long Versions of Conners’ Parent (CPRS-R:L) and
Teacher (CTRS:R:L) Rating Scales [Conners et al., 1998a,b]. From
both scales, we used the nine-item inattention and nine-item
hyperactivity–impulsivity DSM-IV ADHD symptom subscales.
Wechsler intelligence scales for children, third edition (WISC-
III) [Wechsler, 1991]. The vocabulary, similarities, picture com-
pletion and block design subtests from the WISC-III were used to
obtain an estimate of the child’s IQ (prorated following procedures
described by Sattler [1992]).
Reading difficulties. Reading Difficulties Questionnaire
(RDQ) is a subscale of the Colorado Learning Difficulties Ques-
tionnaire [Willcutt et al., 2011]. This six-item parent rating scale is
part of an instrument screening for learning disorders. On a scale
that ranges from 1 (never/not at all) to 5 (always/a great deal),
parents reported the extent of their child’s difficulties with spelling,
learning letter names, sounding words out, and to what extent their
child reads slowly, below expectancy level or has required extra help
at school.
The go/no-go task [van der Meere et al., 1995; Borger and van
der Meere, 2000; Kuntsi et al., 2005]. On each trial, one of two
possible stimuli appeared for 300ms in themiddle of the computer
screen. The child was instructed to respond only to the “go” stimuli
and to react as quickly as possible, but to maintain a high level of
accuracy. The proportion of “go” stimuli to “no-go” stimuli was
4:1. The participants performed the task under three conditions
(slow, fast, and incentive), matched for length of time on task.
Herein, we present data from the slow condition, which had an
inter-stimulus interval of 8 sec and consisting of 72 trials, and the
fast condition, with an inter-stimulus interval of 1 sec and con-
sisting of 462 trials. The order of presentation of the slow and fast
conditions varied randomly across participants. We focus here on
two variables obtained from the task: CE and RTV.
The fast task [Kuntsi et al., 2006; Andreou et al., 2007]. The
baseline condition, with a foreperiod of 8 sec and consisting of 72
trials, followed a standard warned four-choice RT task. A warning
signal (four empty circles, arranged side by side) first appeared on
the screen. At the end of the foreperiod (presentation interval for
thewarning signal), the circle designated as the target signal for that
trial was filled (colored) in. The participant was asked to make a
compatible choice by pressing the response key that directly
corresponded in position to the location of the target stimulus.
Following a response, the stimuli disappeared from the screen and a
fixed inter-trial interval of 2.5 sec followed. Speed and accuracy
were emphasized equally. If the child did not respondwithin 10 sec,
the trial terminated. A comparison condition with a fast event rate
(1 sec) and incentives followed the baseline condition [Andreou
et al., 2007]. Herein, we focus on RTV, obtained from the baseline
condition.
Selection of Clinical Variables for Tests of
Genetic Associations
Tests of allelic association were performed on the exact same final
variables used in corresponding quantitative genetic analysis in
the same twin sample [Paloyelis et al., 2010; Cheung et al., 2014;
Kuntsi et al., 2014]. In brief, parent and teacher ratings on
corresponding ADHD subscales of the CPRS-R:L and CTRS-R:
L [Conners et al., 1998a,b] were summed to obtain composite
subscale measures that were more stable, reliable and situation-
ally pervasive measures of ADHD behaviors. A total reading score
was obtained from summing parent response to the six items of
the RDQ. An overall RTV composite score was obtained across
the two cognitive tasks by summing unstandardized RTV across
the baseline conditions of the go/no-go and fast task. An overall
CE score was obtained across the two conditions by summing the
percentage of CE across slow and fast conditions of the go/no-go
task. The final set of variables included in the molecular genetic
analysis was inattention symptom scores, hyperactivity–impul-
sivity symptom scores, RD scores, RTV and CE. The measures
were regressed to correct for the effects of age and sex (a standard
twin modeling procedure) and non ADHD-subscale ratings were
further regressed for IQ. All measures were then transformed
(with the exception of CE) using the optimized minimal skew
“lnskew0” command in STATA.
Genotyping
Nineteen polymorphisms were selected on the basis of previous
reports of association with ADHD [Bobb et al., 2005; Domschke
et al., 2005; Sheehan et al., 2005; Xu et al., 2005, 2007, 2008; Brookes
et al., 2006; Li et al., 2006; Kim et al., 2007, 2008; Yang et al., 2007;
Lasky-Su et al., 2008a,b; Lesch et al., 2008; Ribases et al., 2008, 2009;
Gizer et al., 2009]. SNPs associated with ADHD in these studies
were included from the following genes: cadherin 13 (CDH13),
ciliary neurotrophic factor receptor (CNTFR), DRD4, HTR1B,
serotonin receptor (HTR2A), monoamine oxidase A (MAOA),
norepinephrine transporter (SLC6A2), SLC6A3, SNAP-25, and
tryptophan hydroxylase 2 (TPH2). Variable Number Tandem
Repeat (VNTR) polymorphisms nominated included: COMT
Val158Met, DRD4 exon 3, SLC6A3 30UTR, SLC6A3 intron 8,
and 5-HTTLPR.
DNA was extracted from buccal swabs (as described elsewhere
[Freeman et al., 2003]). SNPs were genotyped using the Sequenom
MassARRAY system. VNTR polymorphisms were genotypedman-
ually using standard PCR based methods and resolved using
agarose gel electrophoresis, as previously described [Xu et al.,
2005; Brookes et al., 2006; Asherson et al., 2007].
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Genotype error rates were estimated from genotype discordance
rates within MZ twin pairs using PEDSTATS, a feature of the
Quantitative Transmission Disequilibrium Test (QTDT) program
[Abecasis et al., 2000]. SLC6A3 SNPs rs40184 and rs2625211 were
excluded due to a high rate ofMZdiscordance (error rates of 5.70%
and 4.18%, respectively). For the remaining 17 markers, the
average MZ discordance error rate was 1.72%, (ranging from no
error rates to 3.42%) andMZ concordance errors were re-coded as
missing genotypes. After these quality control steps, the 5-HTTLPR
VNTR was omitted as it had a high level (10.4%) of missing data.
Themissing rate for all othermarkers was 2.8–6.1%. All 16markers
used in the final analysis conformed to Hardy–Weinberg equilib-
rium (P> 0.01).
Statistical Analyses
Genetic association. Tests of allelic association were per-
formed using the QTDT program [Abecasis et al., 2000]. QTDT
tests for association with quantitative phenotypes in a variance
components framework. Three models of association were tested
using a likelihood ratio test implemented in QTDT: the “Total
Association” test (AT), the “Within-Test” of association (AW), and
the test of “Population Stratification” (AP).Overall associationwas
tested using the AT model which assesses both the within-pair
differences as well as between pair sums (i.e., the correlation
between phenotypic and genotypic differences and sums for
each twin pair) and is the most powerful test in the absence of
stratification effects. In contrast, the AW assesses the within
component only. The within-pair design of the AW means that
it is unaffected by between-family stratification effects, yet is less
powerful than the AT in the absence of stratification. Stratification
is tested using the AP test, which tests for a significant difference of
the between pair component versus the within pair component of
association. Stratification effects are dismissed when these com-
ponents are equal (P> 0.05) and results are interpreted from the
AT. Conversely, results are interpreted from the AW if significant
stratification effects are detected [Mill et al., 2005].
To correct for multiple testing, a Bonferroni correction for the
16 independent markers analyzed was applied, requiring P< 0.003
to attain study-wise statistical significance. We did not correct for
the number of phenotypes tested as themajority of the quantitative
traits are significantly correlated (0.12–0.59, P< 0.01). Further-
more, we set out to establish whether there was any evidence that
the pattern of findings from the molecular genetic analysis would
match that predicted by the pattern of genetic correlations in twin
studies.
VNTR markers were tested using the “multi-allelic” function in
QTDT.This provides a singleP-value for tests of alleleswith an allele
frequency> 0.05. UNPHASED (http://www.mrc-bsu.cam.ac.uk/
personal/frank/software/unphased/) [Dudbridge, 2008] was used
to test X-linkedMAOAmarker (rs6323) becauseQTDT cannot deal
with such data. UNPHASED has no means for handling MZ twin
data; therefore mean phenotypic scores for MZ pairs were used in
these analyses, and MZ pairs were entered as singletons.
Mediation. Nominal genetic associations that overlapped
across behavioral ratings and cognitive measures, and matched
previous expectation from quantitative genetic findings were taken
forward to test whether associations reflected pleiotropic or medi-
ating genetic effects. Mediation analyses were conducted using a
series of regression analyses performed in STATA. The mediation
model is presented in Figure 1. The coefficient c0 represents the
direct effect of X (the independent variable [predictor; here geno-
type]) onY (the dependent variable; outcome), after controlling for
the effect ofM (the intervening variable; mediator). The coefficient
a represents the effect of the SNP on the mediator, and the
coefficient b represents the effect of the mediator on the outcome.
Therefore, the mediated (or indirect) effect of the SNP on the
outcome via themediator is represented as ab. The total effect of the
SNP on the outcome (including the indirect and direct effect) is
represented by c, and is estimated as abþ c0.
Approaches to test mediation have been subjected to extensive
research over the last two decades [Fairchild and MacKinnon,
2009]. In this paper, we calculate the indirect effect and test it for
significance as suggested by Preacher and Hayes [2004], and adopt
the product of coefficients approach to test the mediating effects of
intervening variables on the genetic association of the number of
risk alleles on questionnaire ratings, which tests the significance
of the mediating variable by dividing the estimate of the indirect
effect (ab) by its standard error, and comparing this value to a
standard normal distribution to test for significance. There are
multiple formulas to estimate the standard error (SE) of the
mediated (ab) effect [see MacKinnon et al., 2002]. We adopt the
most frequently used formula, derived by Sobel: √(a2 SEb2)þ
(b2 SEa2) (where SEa refers to the standard error of a and SEb
refers to the standard error of b) [MacKinnon et al., 2002]. As stated
above, ab is then divided by its standard error, and tested for
FIG. 1. Path diagram for a mediation model. Note: adapted from
[Fritz and MacKinnon, 2008]. X, independent variable; M,
mediating variable; Y, dependent variable. The mediation model
decomposes the total effect of X on Y (c) into two parts: the
indirect effect of X on Y, reflected by ab, and the direct effect of
X on Y with the effect of the mediator removed, reflected by c0.
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significance using MacKinnon’s z distribution. For these analyses,
we adopted an alpha value of 0.05, for which a z value that does not
lie between 1.96 and 1.96 is considered significant.
RESULTS
Association Analyses
Association findings are listed in Table II. The strongest association
was found using the total test of association (AT) for the T-allele of
SNP rs7984966 in HTR2Awith RTV (P¼ 0.007), although this did
not withstand correction for multiple testing. The T-allele of the
same SNP in HTR2S was also nominally associated with RD
(P¼ 0.02). The T-allele of another HTR2A SNP (rs7322347)
showed nominal association with inattention (P¼ 0.01). Increased
RTV was also nominally associated with the G-allele of SNP
rs11646411 in CDH13 (P¼ 0.03). The T-allele of one of the
SNPs (rs3785143) in SLC6A2 showed a nominal AT association
with CE (P¼ 0.03).
Taking into account the presence of population stratification
effects, and therefore using the AW results, nominal AW associ-
ations were found for the T-allele of the other SLC6A2 SNP
(rs3785157) and both hyperactivity–impulsivity (P¼ 0.04) and
CE (P¼ 0.05). In addition, nominal associations emerged between
the G-allele of SNP rs6296 in the HTR1B gene and increased CE
(P¼ 0.02). Althoughwe found anAT nominal association between
the TPH2 SNP rs1843809 and inattention, since there was also
evidence for significant population stratification, the AT associa-
tion was ignored in favor of the AW estimate, which was non-
significant.
None of the associations withstood correction for the number of
SNPs examined, requiring P< 0.003. However, both SNPs in
SLC6A2 are of potential interest because of the overlapping nomi-
nal associations: the T-allele in rs3785143 and CE (P¼ 0.03), and
the T-allele in rs3785157 and hyperactivity–impulsivity (P¼ 0.04)
and CE (P¼ 0.05). In addition further, though weaker, trends
emerged with hyperactivity–impulsivity (T-allele in rs3785143;
P¼ 0.09) and inattention (T-allele in rs3785157; P¼ 0.09). In
addition, HTR2A is of potential interest because of overlapping
associations of the T-allele in rs7984966 SNPwith RTV (P¼ 0.007)
and RD (P¼ 0.02), with a further trend for association with
inattention (P¼ 0.09). Although all the overlapping associations
are nominal and non-significant when adjusted for multiple test-
ing, the observed pattern of findings is consistent with previous
findings derived from our previous genetic model-fitting in the
same sample. Therefore, we tested meditation models for these
overlapping associations with both SLC6A2 SNPs and the HTR2A
SNP rs7984966.
Testing Candidate Mediating Pathways
QTDT associations were observed for the SLC6A2 SNP
(rs3785157) with CE (P¼ 0.05) and both hyperactivity–impulsiv-
ity (P¼ 0.04), and to a lesser extent inattention (P¼ 0.09). There-
fore, we tested two candidate pathways using two separate models
with hyperactivity–impulsivity/inattention modeled as the out-
come in alternative models. As the QTDT associations with
rs3785157 were found using the AW test, within-pair differences
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for phenotype and genotype (specifically risk alleles) were used in
the regression tests for mediation. Although we found overlapping
associations with the other SLC6A2 SNP (rs3785143) and both
hyperactivity–impulsivity and CE, these could not be tested in a
mediation model, as associations in QTDT were mixed (associa-
tions with CE obtained using AT test, and association with hyper-
activity–impulsivity obtained using AW test). Associations were
also observed for the HTR2A SNP rs7984996 with RTV
(P¼ 0.007), RD (P¼ 0.02) and, to a lesser extent, inattention
(0.09), and as these associations were found in the AT test,
difference scores were not used for the regression analysis. Instead,
individual genotype and phenotype data were used, and the
“cluster” command employed to account for the genetic relation-
ship within twin pairs. Only models where significant mediation is
observed are presented (Figs. 2 and 3).
Testing CE as mediating the association between SLC6A2 and
hyperactivity–impulsivity. In the first step of the regression
analysis, we tested pathway c (see Fig. 1), and found that the
SLC6A2 SNP rs3785157 predicted hyperactivity–impulsivity
(pathway c: b¼0.0079, standard error (SE)¼ 0.044,
P¼ 0.073). In the second regression step, we found that the
SLC6A2 SNP rs3785157 significantly predicted CE (pathway a:
b¼ 9.80, standard error (SE)¼ 3.53, P¼ 0.006). In the next step of
the regression analysis, a hierarchical regression analysis was
performed to test pathway b (b¼0.001, SE¼ 0.006,
P¼ 0.079) and c0 (b¼0.07, SE¼ 0.045, P¼ 0.12). The indirect
effect (ab) is estimated at 0.0097, and the SE of ab (SEab) is
estimated at 0.0065 (√(b2 SEa2)þ (a2 SEb2)). The z statistic
was estimated at1.48 (ab/SEab), P¼ 0.14. Therefore, the indirect
(mediated) effect of CE on the association between SLC6A2 and
hyperactivity–impulsivity was not significant.
Testing CE as mediating the association between SLC6A2 and
inattention. The SLC6A2 SNP rs3785157 predicted inattention
(b¼0.046, SE¼ 0.047, P¼ 0.33). The second step in this medi-
ation model is a repeat of the second step in the previous model (as
the SNP andmediator are the same), and so indicated that the SNP
is significantly related to the mediator (CE) (P¼ 0.006). In the
hierarchical regression analysis, CE significantly predicted inatten-
tion (b¼0.0018, SE¼ 0.0006, P¼ 0.003) and when controlling
for the effects of CE on inattention, the effect of rs3785157 on
inattention was b¼0.028, SE¼ 0.047, P¼ 0.55). The indirect
effect (ab) is estimated at 0.017, and the SE of ab is estimated at
0.0086. The z statistic was estimated at2.03, P¼ 0.04. Therefore,
the indirect (mediated) effect of CE on the association between
SLC6A2 and inattention was significant (Fig. 2). The proportion of
the total effect between the SLC6A2 SNP rs3785157 and inattention
that is mediated by CE is 38% ((ab/c) 100).
Testing RTV asmediating the association betweenHTR2A and
inattention. Regression analyses revealed that the HTR2A SNP
rs7984966 predicted inattention (pathway c:b¼ 0.037, SE¼ 0.024,
P¼ 0.13), and RTV (pathway a: b¼ 0.094, SE¼ 0.028, P¼ 0.001).
In the hierarchical regression analysis, RTV significantly predicted
inattention (b¼ 0.17, SE¼ 0.024, P< 0.001) andwhen controlling
for the effects of RTV on inattention, the effect of rs7984966 on
inattention was b¼ 0.017, SE¼ 0.024, P¼ 0.47). The mediated
effect of RTV on the association between the HTR2A SNP
rs7984966 and inattention was significant (ab¼ 0.016, z¼ 2.99,
P¼ 0.003) (Fig. 3). The proportion of the effect of rs7984966 on
inattention accounted for by RTV was 44%.
Testing inattention as mediating the association between
HTR2A and RD. In the first step of the regression analysis, we
tested pathway c, and found that the HTR2A SNP rs7984966
predicted RD (b¼ 0.11, standard error (SE)¼ 0.05, P¼ 0.03).
In the second regression step, we found that the SNP predicted
inattention (pathway a: b¼ 0.037, standard error (SE)¼ 0.024,
P¼ 0.13). In the next step of the regression analysis, a hierarchical
regression analysis was performed to test pathway b and c0. Inat-
tention significantly predicted RD (b¼ 0.98, SE¼ 0.06,P< 0.001),
and when controlling for the effects of inattention on RD, the effect
of the HTR2A SNP rs7984966 on RD was b¼ 0.079, SE¼ 0.045,
P¼ 0.08. The mediated effect of inattention on the association
between the HTR2A SNP rs7984966 and RD was not significant
(ab¼ 0.036, z¼ 1.51, P¼ 0.13).
DISCUSSION
Informed by our previous genetic model-fitting results [Paloyelis
et al., 2010; Cheung et al., 2014; Kuntsi et al., 2014], we investigated
FIG. 2. Mediation model of SLC6A2 on inattention via CE. Note:
CE, commission errors; INATT, inattention.
FIG. 3. Mediation model of HTR2A on inattention via RTV. Note:
INATT, inattention; RTV, reaction time variability.
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the molecular genetic correlates of the two ADHD symptom
domains of inattention and hyperactivity–impulsivity with key
cognitive impairments we have previously shown to be associated
with the genetic risk for ADHD. Using genetic risk alleles from
candidate genes previously reported to be associated with ADHD,
we found that several of the genetic variants showed nominal
associations across phenotypes previously shown to share genetic
risk factors with ADHD. Although none of these withstood cor-
rection for multiple testing, the observed associations are of
potential interest because the pattern of findings is consistent
with previous findings derived from our genetic model-fitting
analyses in the same sample. For this reason, we conducted
mediation analyses on selected SNPs where there was an overall
pattern of findings in line with previous twin model-fitting
findings.
From the mediation tests we obtained preliminary evidence that
RTV mediated the association between the T-allele of rs7984966 in
HTR2A and inattention, and CE mediated the association between
the T-allele of rs3785157 in SLC6A2 and inattention. In contrast,
there was no evidence for the mediating role of inattention in the
association between rs7984966 in HTR2A and RD, or for CE in the
association between rs3785158 in SLC6A2 and hyperactivity–
impulsivity, suggesting pleiotropic (non-mediating) genetic effects.
The strongest association was between the T-allele of SNP
rs7984966 in HTR2A and RTV, which was also associated with
RD, and at trend level with inattention. A further SNP in HTR2A
(rs7322347) was also associated with inattention. These SNPs have
been associated both in single marker and haplotype (multiple
markers) analyses with ADHD (DSM-IV combined type) in both
children and adults [Ribases et al., 2009]. However, our associa-
tions were with the opposite alleles to those reported in the
previous literature [Ribases et al., 2009]. It is interesting to note
that this finding in the opposite direction to the expected effectmay
mirror DRD4 findings in the literature, which suggest that the
absence of the ADHD risk allele is associated with superior RTV
performance [Bellgrove et al., 2008; Kebir et al., 2009; Kebir and
Joober, 2011].
Overlapping nominal associations were also found for two
SNPs in SLC6A2: both SNPs were associated with CE but not
associated with either RTV or RD, and one SNP (rs3785157) was
also further associated with both ADHD behavioral dimensions
(although the association with inattention was at a trend level).
In the analysis, we identified the T allele of the SLC6A2 SNP,
rs3785157, as the risk allele, in line with some studies [Bobb et al.,
2005], but opposing others [Xu et al., 2005]. The association of
both SLC6A2 SNPs with CE are in line with a recent study of
Korean children with ADHD, which found an association with
SLC6A2 and CE [Song et al., 2011].
Overall, the pattern of findings we observed (overlapping asso-
ciations with RTV, inattention and RD; overlapping associations
with CE and both inattention and hyperactivity–impulsivity; and
non-overlapping associations with CE and either RTV or RD) is in
line with the results from our quantitative genetic analyses [Pal-
oyelis et al., 2010; Cheung et al., 2014; Kuntsi et al., 2014].
While these findings are preliminary, based on weak nominal
significance with individual genetic variants, the similar pattern of
findings between themolecular and quantitative genetic findings is
of interest and met our criteria for conducting mediation tests. We
therefore performed mediation analyses to formally distinguish if
overlapping associations reflect pleiotropic or mediating effects
[Kendler and Neale, 2010; Langley et al., 2010] for genetic markers
showing overlapping nominal associations (including trend level
findings consistent with the findings from twin model fitting) with
both a symptom domain and a cognitive variable.
Although overlapping associations suggested that rs3785157 in
SLC6A2 may be a potential genetic candidate contributing to the
association of CE with both ADHD behavioral dimensions, our
further analyses suggested that the overlapping nominal genetic
associations with hyperactivity–impulsivity reflect pleiotropic gen-
etic effects. In contrast, CE mediated 38% of the effect of SLC6A2
on inattention. Another overlapping set of associations was ob-
served for rs7984966 in HTR2A with RTV, RD and inattention,
implicating it as a potential candidate marker, in line with our
previous quantitative genetic finding that the association of RTV
and RD with ADHD largely reflects genetic influences shared with
inattention that are distinct from those underlying hyperactivity–
impulsivity [Paloyelis et al., 2010; Cheung et al., 2014; Kuntsi et al.,
2014]. Mediation analysis indicated that inattention did not sig-
nificantly mediate the effects of HTR2A on RD. In contrast, RTV
significantly mediated a substantial proportion (44%) of the effect
of HTR2A on inattention symptoms. We therefore obtained
preliminary evidence for CE and RTV as intermediate phenotypes
on the pathway to inattention, respectively from the SLC6A2 and
HTR2A genes.
In common with previous studies incorporating quantitative
assessments of ADHD within molecular genetic investigations,
power to detect genetic associations was limited due to a small
sample size. Power for this sample was estimated using the genetic
power calculator from Purcell et al. [2003] and found to be around
80% for nominal significance (P¼ 0.05) for genetic loci explaining
around 0.5% of the phenotypic variance. The genetic associations,
therefore, need to be treated with considerable caution, as none of
the individual associations reported withstood correction for mul-
tiple testing, and did not account for the multiple phenotypes also
targeted. Furthermore, some of the allelic specific associations we
identifiedwerenot in the samedirection aspredictedby theprevious
literature. Despite these limitations, we found nominal associations
with previously implicated ADHD susceptibility genes and psycho-
metrically robustADHD-relatedphenotypes, selectedon thebasis of
quantitative genetic model-fitting analyses. Since the pattern of
findings was consistent with those from the previous quantitative
genetic analyses these are less likely to have arisen by chance.
It is essential that these findings are extended and replicated;
candidate gene associations are notoriously fickle and this could
potentially be the case with the present findings. The next stage of
this approach is already underway with collaboration between
international investigators generating large samples, with clinical
phenotypic data (ADHD symptom counts), cognitive measures
and genome-wide association data. The findings presented here are
nevertheless encouraging and outline a general strategy that can
easily be adapted to the investigation of multiple genetic markers
and polygenic risk scores. Matching genetic association findings to
the predicted patterns of genetically correlated traits, from twin
model fitting and other quantitative genetic designs, may help to
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delineate the role of specific gene or gene pathways, and provides a
framework for testing for the causal (mediating) role of cognitive
endophenotypes on ADHD.
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